Acadia Pharma (ACAD) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $29.01 --0%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q4 EPS of ($0.65), in-line with the analyst estimate of ($0.65). Revenue for the quarter came in at $11.96 million versus the consensus estimate of $9.05 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
